Nuwellis, Inc. (NUWE)

Market Cap	4.14M -5.9%
Revenue (ttm)	8.17M -8.9%
Net Income	-16.56M
EPS	-56.33
Shares Out	1.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	81,599
Open	2.540
Previous Close	2.570
Day's Range	2.200 - 2.540
52-Week Range	1.709 - 62.160
Beta	-0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 10, 2026

About NUWE

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Aus...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 38
• Stock Exchange: NASDAQ
• Ticker Symbol: NUWE
• Website: https://www.nuwellis.com

Financial Performance

In 2024, Nuwellis's revenue was $8.74 million, a decrease of -1.40% compared to the previous year's $8.86 million. Losses were -$10.62 million, -53.05% less than in 2023.